The global hexamethylene tetramine (hexamine) market​ is projected to grow from a valuation of USD 100–200 million in 2025 to USD 2.36 billion by 2035, demonstrating a steady compound annual growth rate (CAGR) of 4.5%–5.5%​ through the forecast period . This heterocyclic organic compound, also known as HMTA or urotropine, has become indispensable across phenolic resin production, rubber processing, agrochemical formulations, and pharmaceutical applications. Understanding the dynamic global buyer landscape​ for hexamine is essential for chemical suppliers, distributors, and stakeholders seeking to capitalize on emerging opportunities in this evolving market. This comprehensive analysis examines key purchasing industries, regional procurement patterns, supplier capabilities, and strategic considerations defining the global hexamine trade…